Neuroimaging of pediatric tumors of the sellar region-A review in light of the 2021 WHO classification of tumors of the central nervous system
Sellar/suprasellar tumors comprise about 10% of all pediatric Central Nervous System (CNS) tumors and include a wide variety of entities, with different cellular origins and distinctive histological and radiological findings, demanding customized neuroimaging protocols for appropriate diagnosis and...
Saved in:
Published in: | Frontiers in pediatrics Vol. 11; p. 1162654 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
21-06-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Sellar/suprasellar tumors comprise about 10% of all pediatric Central Nervous System (CNS) tumors and include a wide variety of entities, with different cellular origins and distinctive histological and radiological findings, demanding customized neuroimaging protocols for appropriate diagnosis and management. The 5th edition of the World Health Organization (WHO) classification of CNS tumors unprecedently incorporated both histologic and molecular alterations into a common diagnostic framework, with a great impact in tumor classification and grading. Based on the current understanding of the clinical, molecular, and morphological features of CNS neoplasms, there have been additions of new tumor types and modifications of existing ones in the latest WHO tumor classification. In the specific case of sellar/suprasellar tumors, changes include for example separation of adamantinomatous and papillary craniopharyngiomas, now classified as distinct tumor types. Nevertheless, although the current molecular landscape is the fundamental driving force to the new WHO CNS tumor classification, the imaging profile of sellar/suprasellar tumors remains largely unexplored, particularly in the pediatric population. In this review, we aim to provide an essential pathological update to better understand the way sellar/suprasellar tumors are currently classified, with a focus on the pediatric population. Furthermore, we intend to present the neuroimaging features that may assist in the differential diagnosis, surgical planning, adjuvant/neoadjuvant therapy, and follow-up of this group of tumors in children. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Abbreviations ACP, Adamantinomatous craniopharyngioma; ACTH, Adrenocorticotropic hormone; ADC, Apparent diffusion coefficient; AT/RT, Atypical teratoid/rhabdoid tumor; β-HCG, Beta-human chorionic gonadotropin; CBF, Cerebral blood flow; CISS, Constructive interference in steady state; CNS, Central nervous system; CT, computed tomography; DCEI, Dynamic contrast-enhanced imaging; ECD, Erdheim-Chester Disease; DRIVE, Driven equilibrium radio frequency reset pulse; DWI, Diffusion weighted imaging; FIESTA, Fast imaging employing steady-state acquisition; FLAIR, Fluid attenuated inversion recovery; GCT, Germ cell tumors; JXG, Juvenile xanthogranuloma; LCH, Langerhans cell histiocytosis; MEN-1, Multiple endocrine neoplasia type 1; MRI, magnetic resonance imaging; NF1, Neurofibromatosis type 1; OPG, Optic pathway glioma; PCP, papillary craniopharyngioma; PitNET- Pituitary neuroendocrine tumor; RCC, Rathke's cleft cyst; SCO, Spindle cell oncocytoma; SPACE, Sampling perfection with application optimized contrast using different flip angle evolution; SWI, Susceptibility weighted imaging, WHO- World Health Organization. Edited by: Fabrício Guimarães Gonçalves, Childrens Hospital of Philadelphia, United States Reviewed by: Flavio Giordano, University of Florence, Italy Joseph Louis Lasky, Cure 4 The Kids, United States Cesar Augusto Alves, Childrens Hospital of Philadelphia, United States |
ISSN: | 2296-2360 2296-2360 |
DOI: | 10.3389/fped.2023.1162654 |